Actinium Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Actinium Pharmaceuticals has a total shareholder equity of $38.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $82.1M and $43.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$78.66m |
| Equity | US$38.21m |
| Total liabilities | US$43.91m |
| Total assets | US$82.11m |
Financial Position Analysis
Short Term Liabilities: ATNM's short term assets ($79.5M) exceed its short term liabilities ($7.8M).
Long Term Liabilities: ATNM's short term assets ($79.5M) exceed its long term liabilities ($36.2M).
Debt to Equity History and Analysis
Debt Level: ATNM is debt free.
Reducing Debt: ATNM has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ATNM has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ATNM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.